The PmrA-PmrB two-component regulatory system of Salmonella enterica serovar Typhimurium is activated in vivo and plays an important role in resistance to cationic antimicrobial peptides. Resistance is partly mediated by modifications to the lipopolysaccharide. To identify new PmrA-regulated genes, microarray analysis was undertaken comparing cDNA derived from PmrA-constitutive and PmrA-null strains. A combination of RT-PCR and transcriptional analysis confirmed the inclusion of six new loci in the PmrA-PmrB regulon: STM1253, STM1269, STM4118, STM0459, STM3968 and STM4568. These loci did not affect the ability to grow in high iron conditions, the ability to modify lipid A with aminoarabinose, or virulence. STM4118, a putative phosphoethanolamine phosphotransferase, had a minor effect on polymyxin resistance, whereas the remaining genes had no role in polymyxin resistance. Although several of the identified loci lacked the consensus PmrA binding site, PmrA was demonstrated to bind the promoter of a PmrA-activated gene lacking the consensus site. A more complete definition of the PmrA-PmrB regulon will provide a better understanding of its role in host and non-host environments.
Introduction
Survival of the enteric pathogen Salmonella enterica serovar Typhimurium in the host depends partly on the ability of the bacteria to resist killing by cationic antimicrobial peptides (AP), a central component of mammalian innate immunity [1, 2] . In mammals, AP are produced at mucosal surfaces and in the granules of professional phagocytes [3] [4] [5] [6] . S. enterica serovar Typhimurium thus encounters AP during the course of infection at mucosal surfaces of the gastrointestinal tract. In addition, salmonellae encounter AP in phagocytic cells of the lamina propria, mesenteric lymph nodes, liver and spleen during enteric fever in humans and in the mouse model of infection. Many studies have demonstrated a correlation between bacterial resistance to AP and survival within the mammalian host (and in vitro with mammalian cells), signifying the importance of this phenotype in pathogenesis [7] [8] [9] [10] [11] .
S. enterica serovar Typhimurium can circumvent elimination by AP by up-regulating expression of two two-component regulatory systems, PhoP-PhoQ and PmrA-PmrB, in response to specific cues from the host environment [12] [13] [14] . Activation of PmrA-PmrB leads to modification of the lipopolysaccharide (LPS) lipid A with aminoarabinose (Ara4N), and core and lipid A with phosphoethanolamine (pEtN) [15] . PmrA mediates induction of pmrE and pmrHFIJKLM, which encode enzymes involved in the biosynthesis of Ara4N and its addition to the 4 0 -phosphate (and sometimes 1-phosphate) of the lipid A [7, [14] [15] [16] [17] . Modification of LPS with Ara4N results in increased bacterial resistance to the AP polymyxin B (PM), and to neutrophil cationic antimicrobial proteins CAP-57 (bactericidal permeability-increasing protein, BPI) and CAP-37 (azurocidin), but not to defensins or several other AP subtypes [18] [19] [20] . A strain expressing constitutively active PmrA (PmrA C , pmrA505) produces LPS extensively modified with Ara4N and pEtN and has reduced susceptibility to PM. PmrC, located in an operon with pmrA and pmrB, mediates pEtN addition to lipid A and plays a minor role in PM resistance [21] .
A PmrA-null mutant demonstrates increased susceptibility to PM, poor growth in high iron media, as well as attenuated virulence in the murine host [7, 14, 22] . Mutations in pmrE and pmrF also decrease bacterial survival in the mouse, presumably by precluding the addition of Ara4N to lipid A and increasing susceptibility to host AP [7] . In this study, we undertook DNA microarray analysis comparing cDNA derived from the PmrA C strain and from the PmrA-null strain in order to investigate the possibility of additional PmrA-regulated genes that may play a role in PmrA-mediated LPS modification, virulence or other unknown phenotypes. We report here the genes verified to be regulated by PmrA and the roles of the identified genes in contributing to phenotypes associated with the PmrA-PmrB regulon.
Materials and methods

Bacterial strains and growth conditions
Bacterial strains used in this study are described in Table 2 . Salmonellae were grown in Luria-Bertani (LB) broth at 37°C with aeration, unless otherwise specified. Antibiotics were used, when appropriate, at the following concentrations: polymyxin B (PM), 8 lg/ml; chloramphenicol, 25 lg/ml; kanamycin, 45 lg/ml; and tetracycline, 25 lg/ml. For high iron growth experiments, strains were grown on solid N-minimal media, pH 5.8, containing 10% casamino acids, 38 mM glycerol, 10 lM MgCl 2 , and 0.1 mM FeSO 4 [22] .
DNA microarray experiments
To identify genes regulated by PmrA, we undertook DNA microarray analysis to compare transcription levels of genes in PmrA C and PmrA-null backgrounds. JSG435 (PmrA C ) and JSG421 (PmrA-null) were grown in LB broth at 37°C with aeration. Samples were collected at an OD 600 of 0.350 and 0.6 (early-and mid-logarithmic phase of growth.) RNA was isolated using the QIAgen RNeasy Mini Kit (Qiagen, Inc., Valencia, CA) using the protocol specified by the manufacturer. Using these RNA templates, cDNA was synthesized using pd(N) 6 Random Hexamer (Amersham Biosciences, Piscataway, NJ) and labeled with Cy3 or Cy5 dyes as described previously [23] . Labeled cDNA was hybridized to DNA microarrays from S. enterica serovar Typhimurium SL1344 [24] . Hybridized microarray slides were scanned and analyzed using a Gene Pix Scanner [25] . For each time point, three hybridizations were grouped in an experimental set and were filtered by the Stanford University Microarray Database based on the mean log 2 -(Cy5/Cy3) ratios. Initial filtering criteria included that at least 80% of the data from a specific spot have a regression correlation of 0.6 over three independent experiments. Data were filtered using Cluster software to eliminate genes with missing values in over 20% of the experiments and with standard deviations for observed values of greater than 2. Data from the array experiments described herein are available at www.genome-www5.stanford.edu/cgi-bin/search/basicSearch.pl (basic search; results type ''experiments''; choose organism ''S. enterica serovar Typhimurium''; data identifier ''mutants'') [26] .
Reverse transcriptase PCR and densitometry analysis
For reverse transcriptase PCR (RT-PCR) studies, RNA was isolated from 1 · 10 9 mid-logarithmic phase JSG435 (PmrA C ) and JSG421 (PmrA-null) cells using the QIAgen RNeasy kit. cDNA was derived from JSG435 and JSG421 RNA using random hexamers and Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA). 50 ng cDNA was used for PCR analysis with primer pairs designed to amplify internal portions ($400 bp) of the genes under investigation. PCR reactions were performed using Herculase (Stratagene) or Vent (New England Biolabs) polymerases, with a 30 s extension time, an annealing temperature of 52°C, for 30 cycles. Occasionally, PCR conditions were optimized for a particular gene. All primer sequences used in this study can be found at http://medicine.osu.edu/mvimg/ 1188.cfm. All RT-PCR analyses were performed in triplicate using independent RNA and cDNA preparations.
Generation of mutations in genes identified by microarray
Mutations were generated using the k red recombinase and FLP-mediated recombination strategy developed by Datsenko and Wanner [27] using the k red recombinase-encoding plasmid pKD46 (bla P BAD gam bet exo pSC101 oriTS). Each gene was interrupted in wild type, PmrA C and PmrA-null backgrounds using gene replacement with a kanamycin resistance cassette (pKD4; bla FRT ahp FRT PS1 PS2 oriR6K). Recombination of the Kan resistance gene at the intended loci was verified by PCR. Non-polar deletions were generated using the methods also described by Datsenko and Wanner with plasmid pCP20 (bla cat cI 857 kP R flp pSC101 oriTS) [27] . Transcriptional fusions (lacZ) were generated to each gene in both the PmrA C and PmrA-null background strains using site-specific recombination between the FLP-recognition target (FRT) ''scar site'' generated in the deletion strains and that in pCE36 (ahp FRT lacZY + t his oriR6K) [28] . Using this technique, the fusions also yield gene knock outs.
Strains combining a deletion in STM0459 with transcriptional fusions (lacZ) were generated by transducing JSG1867 (PmrA C , D STM0459) with P22 phage propagated on strains containing a transcriptional fusion to the gene of interest (JSG899, JSG1892, JSG2210, JSG2212), yielding JSG2451, JSG2452, JSG2454 and JSG2455, respectively.
Minimal inhibitory concentration and transcriptional assays
The minimal inhibitory concentration (MIC) for PM of each mutant was obtained as previously described [29] , testing serial dilutions of PM (US Biochemicals, 8040 U/mg) in 0.2% BSA-0.01% acetic acid. b-galactosidase assays were performed as described previously [14] . Firefly luciferase assays were performed using 100 ll of cells grown to mid-logarithmic phase (optical density at 600 nm $0.6). Cells were suspended in luciferase buffer (25 mM Tris phosphate, pH 7.8; 2 mM dithiothreitol; 2 mM EDTA, pH 8.0; 10% glycerol; 1% Triton X-100), then sonicated briefly. Cell debris was removed by centrifugation. Assays were performed using 10 ll lysate using an EG&G Berthold Lumat LB 9507 luminometer and luciferase assay reagents from Promega (Luciferase Assay System). All MIC and transcriptional assays were performed in triplicate.
Mass spectrometric analysis of lipid A
LPS was isolated using hot phenol-water methods as previously described [30] . Lipid A was hydrolyzed from LPS and purified using techniques described by Caroff et al. [31] . Purified lipid A was dissolved in 5 ll 5-chloro-2-mercaptobenzothiazole (CMBT) and analyzed by negative ion matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry [7, 32] . Mass spectrograms were examined for the presence of Ara4N based on known peak locations at m/z 1929 (hexa-acylated lipid A with Ara4N) and 2167 (hepta-acylated lipid A with Ara4N) [7, 32, 33] .
Virulence assays
The Kan resistance gene insertions were moved into a wild type S. enterica serovar Typhimurium background via P22 phage-mediated transduction to yield JSG1521-1526. Survival assays were performed using these strains as described previously [7] . Briefly, each mutant, as well as wild type (JSG224) and PmrA-null control (JSG421), was grown to stationary phase (16 h) at 37°C. Approximately 5 · 10 6 stationary phase bacteria (1 log unit above the 50% lethal dose, LD 50 ) were washed and resuspended in 20 ll of phosphate buffered saline, pH 7.4 (PBS). Female BALB/c mice (weighing 16-18 g) were inoculated orally using the swallowing reflex of the mouse. Dilutions of the stationary phase cultures were plated to enumerate the bacteria present in the inocula. Infected mice were observed for 21 days post inoculation.
Promoter binding studies
PmrA-6XHis protein was purified as described previously [7] . Labeled promoter fragments were generated using the Fluorolink Cy5-dCTP Kit (Amersham Pharmacia Biotech) by the manufacturerÕs protocol. Cy5-dCTP was incorporated into PCR-amplified promoter fragments with Taq polymerase. The yibD promoter was PCR amplified from wild type ATCC 14028s using primers JG591 and JG592 such that the fragment began 100 bp upstream of, and overlapped with, the ATG start site. The promoter for dgoA is located upstream of the dgoRKAT operon, and was amplified using primers JG535 and JG536 (incorporating Cy5-dCTP) to produce a 160 bp fragment.
Initial binding reactions were accomplished using serial dilutions of PmrA (0.78-600 ng protein). Binding buffer consisted of 10 mM Tris-HCl (pH 7.5), 1 mM EDTA, 100 mM KCl, 0.1 mM dithiothrietol (DTT), 5% glycerol, 10 mg BSA, and poly d(I-C) non-specific competitor. 10 ng of probe was used in all reactions (20 ll final reaction volume). Reaction tubes were incubated for 30 min at room temperature, then separated on a 6% acrylamide-TBE gel. Fluorescence was detected using the Typhoon phosphorimagery system (BioRad).
Results
DNA microarray analysis identified both PmrAactivated and -repressed genes
To identify genes regulated by PmrA, DNA microarray experiments were performed to compare the relative fluorescence of differentially labeled cDNA derived from PmrA C (JSG435) and PmrA-null (JSG421) strains. Forty-one genes scored greater than the selected threshold of 2.0 according to the criteria described above, suggesting these genes are activated by PmrA (Table 1) . Among the genes were several previously characterized PmrAactivated genes: pmrH (STM2297), pmrF, pmrC (yjdB), pmrA (basR), pmrB (basS), yibD and pmrG (ais). Other known PmrA-activated genes were not present, including pmrE (ugd), other genes of the pmrHFIJKLM operon, dgoA [34] , or the more recently identified PmrA-activated genes found by in silico analyses [35] . Following the same criteria (score of À2.0 or less), only six loci were identified as PmrA-repressed, suggesting that PmrA functions predominantly as a transcriptional activator (Table 1) .
3.2. RT-PCR and transcriptional assays confirmed PmrAregulation of a subset of genes identified by microarray Thirty-five genes that scored greater than 2.0 (excluding known PmrA-activated genes, except pmrH, which was retained as a control) were selected as potential new PmrA-activated genes. The six genes that scored lower than À2.0 were selected as potential PmrA-repressed genes.
To quantify the degree of transcriptional regulation of the putative PmrA-activated and -repressed genes, lacZ transcriptional fusions were generated to each of the loci in PmrA C and PmrA-null backgrounds, and b-galactosidase assays were performed (Fig. 1) . Of the potential PmrA-activated genes, six loci showed a significant difference in activation by PmrA, partially confirming the results of the microarray. Transcriptional assays using luciferase fusions to select genes corroborated these results (data not shown). Although some loci showed a relatively small increase in transcription in a PmrA c background, based on the repetitiveness of this result and the activation also seen in the microarrays, luciferase assays, and RT-PCR reactions (see below), we feel that all six identified loci are PmrAB-regulated.
Reverse transcriptase PCR was also used to screen all 40 predicted PmrA-regulated genes (activated plus repressed) for differential expression in PmrA C and PmrA-null strains. Internal regions of the loci were amplified from cDNA derived from exponential-phase JSG435 and JSG421, and PCR products were visualized by ethidium bromide staining. RT-PCR and densitometry analysis largely confirmed PmrA-regulation of the same six gene subset identified from the DNA microarray and corroborated by b-galactosidase and firefly luciferase fusions (data not shown). STM0459, which showed significantly different levels of transcription in PmrA C and PmrA-null backgrounds, produced inconsistent results in RT-PCR assays. However, due to the consistent reporter fusion results with this gene, it has been classified as PmrAB-regulated. Those that supported the original findings of the array consist of the following PmrA-activated genes (including the predicted protein products): STM1253, putative inner membrane protein; STM1269, putative chorismate mutase; STM4118, putative integral membrane protein; STM3968, uridine phosphorylase; STM4568, thymidine phosphorylase; STM0459, AsnC family transcriptional regulator. None of the six potential PmrA-repressed genes identified by the microarray could be confirmed by any other method.
Analysis of resistance and LPS phenotypes
In order to determine the role of the newly identified PmrA-regulated genes in pmrA-associated phenotypes, such as PM sensitivity and poor growth on high iron media, genes that were verified as PmrA-regulated were mutagenized for further study.
It has been demonstrated that pmrA, as well as pmrL and pmrM (pbgE2 and pbgE3, respectively), are necessary for growth in high iron conditions [22] . PmrA-regulated gene mutants (in a PmrA C background) were assayed for growth on high iron solid media described previously [22] . No strain containing mutations in a PmrA-regulated gene identified in this study showed reduced growth compared to the PmrA C parent, whereas the PmrA-null strain was unable to grow on this media (data not shown).
MICs for PM were determined by testing 10 5 bacteria against serial dilutions of PM in 0.2% bovine serum albumin-0.01% acetic acid [29] . Mutants containing a kanamycin gene replacement in PmrA C and PmrA-null backgrounds, as well as parent strain controls, were included in the assays. The MIC of the STM2297 (pmrH) mutant (2 lg/ml PM) and PmrA-null mutant (0.03 lg/ml PM) were appropriately low compared to the MIC of the PmrA C parent strain (8-12 lg/ml PM). One new PmrA-regulated gene mutant showed a defect in PM resistance. Mutation of STM4118, which encodes a putative integral membrane protein, caused a 2-fold reduction in MIC (4 lg/ml PM) compared to the PmrA C strain. Interestingly, STM4118 is homologous (23% identity, 38% similarity) to lpt-3 of Neisseria meningitidis, a gene necessary for modification of heptose II of core and believed to encode an lipooligosaccharide (LOS) pEtN transferase [36] . Thus, STM4118 may be a PmrA-activated gene responsible for modification of LPS core with pEtN in S. enterica serovar Typhimurium. However, if so, the pEtN modification of core does not appear to contribute dramatically to AP resistance.
To determine whether the PmrA-regulated genes identified herein affect lipid A structure (particularly for STM4118, which demonstrated somewhat decreased PM resistance), purified lipid A from each mutant (PmrA C background) was compared to that of the parental strain for the presence of Ara4N. No obvious differences were seen in relative intensities of substituted and unsubstituted lipid A species derived from the mutants and the PmrA C control (data not shown). Lipid A from the STM4118 mutant was extensively modified with Ara4N, in similar levels as the PmrA C parent, demonstrating that the decreased PM resistance seen in the STM4118 mutant was not due to deceased substitution of lipid A with Ara4N.
Survival of mutants in the murine model
A PmrA-null mutant has been demonstrated to have a virulence defect when administered orally to mice [7] . Additionally, previously identified PmrA-activated genes, such as pmrE and pmrF that affect Ara4N biosynthesis, have been shown to play a role in virulence of S. enterica serovar Typhimurium in mice [7, 14] . The effect of the PmrA-regulated genes identified in these studies on the ability of the bacteria to cause disease in mice was assessed.
Strains with mutations in PmrA-regulated genes were examined for attenuation of virulence in the BALB/c mouse model. All mutations examined were generated in a wild type background, and wild type 14028s and PmrA-null controls were included in these assays [7] . All mice that were infected with a PmrA-regulated gene mutant succumbed to infection within the same time frame (7-9 days) as mice infected with wild type S. enterica serovar Typhimurium and demonstrate no apparent virulence defects. Interestingly, STM4118, which was shown to affect PM resistance, did not affect virulence.
Many PmrA-regulated genes lack the consensus PmrA binding site
For further characterization of the PmrA-regulated gene mutants, the promoter regions of the identified PmrA-activated genes were inspected for the presence of a putative PmrA-binding site, which was defined by the occurrence of the consensus binding sequence for PmrA, YTTAAK-N 5 -YTTAAK (Y = C/T, K = G/ T) [37] . Strong matches to the consensus sequence were found in the promoter regions of STM4118, STM1253 and STM1269 (63, 63 and 60 bp upstream of the translational start sites, respectively) (Fig. 2) . The YT-TAAK repeats described by Aguirre et al. are conserved in all three promoters. Using site directed mutagenesis, Marchal et al. [35] demonstrated that the third and fifth positions of the first hexameric repeat are essential for binding by PmrA; these are conserved in the STM1269, STM1253 and STM4118 promoters.
The remaining PmrA-regulated genes lack the consensus binding sequence, and do not appear to have any other sequence in common. Lack of a consensus PmrA-binding site suggests that regulation of the gene by PmrA may be indirect for these loci, or that PmrA may bind promoter sequences other than those published. To determine whether PmrA can bind directly to promoter fragments of PmrA-regulated loci that lack the published PmrA consensus binding site, gel mobility shift assays were performed to compare the ability of purified PmrA to bind the promoters of yibD and dgoR-KAT [34] . These loci represent PmrA-activated genes, like those identified in this study, that are regulated by PmrA at the transcriptional level and that do contain (yibD) or do not contain (dgoRKAT) the consensus binding site (within a 200 bp region upstream of the translational start).
no match STM1257 no match STM0459 no match STM3968 no match STM4568 no match Fig. 2 . Identification of consensus PmrA binding sites within the promoters of PmrA-activated genes. The consensus PmrA binding sites shown for pmrCAB and yibD were identified previously [34, 37] . The YTTAAK direct repeats are marked in bold and underlined. The translation start sites are underlined. For STM1269, STM1253 and STM4118, the putative PmrA consensus binding site begins 67, 60, 63 and 63 bp upstream of the translational start site, respectively. The third and fifth positions in the first hexameric repeat, which are essential for PmrA binding [35] , are conserved for each of these promoters. No match to the consensus binding site was identified for the remaining PmrA-regulated genes. Fig. 3 . Binding of PmrA to promoters of PmrA-activated genes. To determine whether PmrA is capable of binding promoters lacking the consensus binding site [37] , in vitro binding assays were performed. PmrA was able to bind the yibD promoter, which contains the consensus site (lane 1, yibDp alone; lane 2, yibDp plus 300 ng PmrA). PmrA was similarly able to bind the dgop1 promoter, which lacks the consensus site (lane 3, dgop1 alone; lane 4, dgop1 plus 300 ng PmrA). For both yibDp and dgop1, 100 ng PmrA was sufficient to shift the promoter fragments (data not shown). To determine the specificity of binding of PmrA to dgop1, PmrA was incubated with dgop1 and specific or non-specific cold (unlabeled) competitors. Lanes 30-7 contain dgop1, 600 ng PmrA, plus 2-fold serial dilutions of unlabeled dgo p1 promoter fragment (specific competitor) starting at 50 ng; lanes 9-10 contain dgop1, 600 ng PmrA, plus high amounts of two different un-related DNA fragments of similar size to dgop1.
PmrA bound the yibD promoter in a concentration dependent fashion: 100 ng of PmrA was adequate for a mobility shift, but the clearest shift appeared when 300 ng or more of PmrA was used in the binding reaction (Fig. 3 and data not shown) . Similar amounts of PmrA were able to shift the dgop1 fragment as the yibD promoter, despite the absence of a consensus PmrA binding sequence (Fig. 3) . Binding was confirmed to be specific, because unlabeled (cold) dgop1 competed with Cy5-labeled dgop1 for binding by PmrA, preventing a shift of the labeled promoter fragment (Fig. 3,  lanes 5-9) . Moreover, non-specific cold competitors did not interfere with interaction between PmrA and dgop1 (Fig. 3, lanes 10 and 11) .
Discussion
The PmrA-PmrB regulon controls the expression of a number of well-characterized loci that participate in modification of the lipid A portion of LPS with Ara4N. Substitution of lipid A with Ara4N has been demonstrated to be essential for resistance to the AP polymyxin, CAP-37 and CAP-57, as well as for virulence in the murine host [7, 14] . In addition, PmrA activity is necessary for modification of LPS with pEtN [15, 21] , although all of the PmrA-regulated gene(s) involved in producing the pEtN substitutions have not been previously described.
The use of DNA microarrays to compare gene expression identified 40 loci potentially regulated by PmrA plus several genes previously shown to be part of the PmrA-PmrB regulon. The DNA microarray experiments were shown to be imperfect, because several known PmrA-regulated genes were not detected, and because not all genes showing two-fold or greater regulation by the arrays could be verified as PmrA-regulated (false-positives). Subsequent characterization of these loci by RT-PCR and transcriptional analysis validated 20% of the predicted PmrA-regulated genes. Six genes were shown to be activated by PmrA: STM1253, putative inner membrane protein; STM1269, putative chorismate mutase; STM4118, putative integral membrane protein; STM3968, uridine phosphorylase; STM4568, thymidine phosphorylase, and STM0459, AsnC family transcriptional regulator. No PmrA-repressed genes have been identified to date, and only six genes scored below À2.0 in the microarray experiments. Subsequent RT-PCR and transcriptional analyses failed to confirm repression of any of the six genes by PmrA. Thus evidence suggests that PmrA may function exclusively as a transcriptional activator.
PmrA positively regulates transcription of two putative nucleoside phosphorylases, STM3968 (udp) and STM4568 (deoA) [38] [39] [40] [41] . Thymidine and uridine phosphorylases function in the respective pyrimidine salvage pathways, and so participate in the catabolism of the pyrimidine into the corresponding free base and pentose-1-phosphate [42] . Because Udp and DeoA activity results in increased pools of pyridine bases, up-regulation of udp and deoA may indicate a greater need for DNA replication in host cells. Activation of these loci by PmrA suggests a mechanism by which the bacteria could increase replication specifically in the host.
STM0459 encodes a putative AsnC family transcriptional regulator [40] . Current work is directed toward determining how this system may interact with PmrAB and or PhoPQ. In addition, genes regulated by the product of STM0459 are being determined. Recent data has demonstrated that the PmrAB and PhoPQ systems interact with several other regulatory proteins to mediate control of some regulated genes [43] [44] [45] . Therefore, it would not be surprising if additional members of this regulatory cascade exist.
STM1269 encodes a putative chorismate mutase, an enzyme that functions in phenylalanine and tyrosine biosynthesis [40] . The chorismate mutase aroQ (or biosynthesis of aromatic amino acids in general) has been suggested to play a role in virulence based on the attenuating effect of mutations in aroA, aroC and aroD, which act in the same biosynthetic pathway [46] . However, Salmonella encodes several redundant chorismate mutase genes, so their importance in virulence is unclear [47] . Moreover, unlike aroA, STM1269 mutation had no effect on bacterial survival in the host. Interestingly, during a screen of random mutants in Neisseria gonorrhoeae for PM sensitivity, a chorismate mutase mutant was identified (JSG, unpublished results). Thus chorismate mutase may affect AP resistance in a number of Gram-negative bacteria, but as a single gene mutation, STM1269 of Salmonella was not essential for resistance to PM. STM4118, which is predicted to encode an integral membrane protein [40] , showed a small effect on PM resistance; mutation of STM4118 resulted in a two-fold reduction in PM resistance compared to the parental strain. In addition, a STM4118 mutant showed no attenuation of virulence, suggesting that the decreased PM resistance seen was not sufficient to cause decreased survival in vivo. The similarity of the gene to a pEtN transferase recently characterized in N. meningitidis (which was not examined for a role in AP resistance in N. meningitidis) advocates a role of STM4118 in substitution of LPS with pEtN in S. enterica serovar Typhimurium [36, 48] . The PmrC gene product was recently shown to add pEtN to lipid A [21] , and we predict that the product of STM4118 adds pEtN to the other known site of modification, the LPS core region. If so, the pEtN modification of core does not contribute dramatically to AP resistance. These results are contrary to the expected phenotypes of a pEtN transferase mutant, based on the prediction that pEtN substitution of LPS phosphates would reduce anionic charge of the LPS and decrease binding of LPS with AP. However, Lee et al. [21] demonstrated that the loss of pmrC and the pmrHFIJKLM operon (also called the pbg operon) resulted in PM resistance equal to that of a pmrA mutant strain, suggesting a limited role for PmrAB-regulated core modification in PM resistance. Analysis of the structure of LPS isolated from a STM4118 mutant will allow us to determine the role of the gene product in Salmonella LPS modification.
The consensus promoter binding sequence for PmrA has been characterized based on in vitro binding assays using the promoters of pmrCAB, pmrHFIJKLM, and pmrE (ugd), and consists of hexameric repeats separated by five bases: YTTAAK-N 5 -YTTAAK [37] . Strong matches to this sequence were detected in the promoter regions of STM4118, STM1253 and STM1269, but not in the other PmrA-activated genes. The third and fifth positions in the first hexameric repeat, which have been shown to be essential for binding by PmrA [35] , are conserved in the STM4118, STM1253 and STM1269 promoters. This is particularly important regarding the promoters of STM4118 and STM1253, in which the PmrA binding site diverges from the consensus sequence, but is conserved at the third and fifth positions. The deviation of the STM4118 and STM1253 consensus sequences from the published consensus may explain why Marchal et al. [35] were unable to identify these genes in their survey as they specifically searched for promoters containing the original CTTAAT hexameric repeats. These variations, as well as those in the five bases between the hexamers, may influence the affinity of PmrA for the promoters, and thus impact the degree of gene activation by PmrA. In addition, the lack of consensus PmrA-binding sites in the promoters of STM1257, STM3968, STM4568 and STM0459 suggested that these genes may be indirectly activated by PmrA. It was demonstrated that, in vitro, PmrA can bind to the dgoRKAT promoter, which is a PmrA-regulated gene identified in a previous study which also lacks the PmrA-binding site. PmrA thus can directly and specifically bind promoters lacking the published binding site. Unphosphorylated PmrA was used in these assays and has been previously shown to bind DNA, though the phosphorylated form binds with greater affinity [37, 49] . It is possible that phosphorylation might alter the DNA sequence to which PmrA binds, but this assertion is not well supported in the literature. Further analysis of the PmrA binding site in the promoters of PmrA-regulated genes lacking the consensus binding site will be necessary to identify the features common to all PmrA-activated promoters, if any exist.
These studies identified six new members of the PmrA regulon. Phenotypic characterization of strains with mutations in the PmrA-regulated loci determined that the genes are not essential for high level AP resistance or for virulence of Salmonella in the mouse. As such, these loci may play a non-essential role during infection, have duplicative functions with other proteins in the bacterium, or are pertinent to non-murine or non-host environments.
